increased or decreased according to the change of business circumstance and relevant factors in the near future while the fixing of the base price with certain discount will be used as a minimum price
(3) -103% Elimination (73) (41) 6 108% 115% (228) (134) 41% Profit attributable to owners of the Company 918 1,316 1,386 51% 5% 4,773 5,778 21% Basic earnings per share (Baht) 0.67 0.96 1.01 3.47 4.20
Officer to have an authority to consider, decide, amend or change rules, conditions and details which are necessary and relating to Acquisition and Acceptance of Transfer of the Entire Business as it deemed
authorized the executive committee or the Chief Executive Officer or the person entrusted by executive committee or the Chief Executive Officer to have an authority to consider, decide, amend or change rules
DCORP 025/2020 May 13, 2020 Subject: Management Discussion and Analysis – Explanation of net profit for the quarter ended March 31, 2020 and the increase in the overall operations of more than 20 percent
59 61 23% 19% Core EBIT 204 81 148 152% 38% Core Net Profit after Tax and NCI4 118 48 50 146% 135% Core Net Profit after Tax and NCI (THB m) 3,560 1,459 1,562 144% 128% Core EPS after PERP Interest
enhanced device margin. AIS reported a net profit of Bt8,788mn, increasing 7.9% YoY reflecting strong operating performance, while increasing 2.5% QoQ from higher foreign exchange rate gain. 3Q24 MD&A
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
DCORP 041/2020 August 13, 2020 Subject Management Discussion and Analysis – Explanation of net profit for the quarter ended June 30, 2020 and the increase in the overall operations of more than 20 percent
and 36.0% in 1Q16 following softer handset subsidies and one- time USO fee booked in 1Q16. Net profit was Bt7,693mn, improved 19% QoQ but dropped 4.7% YoY. FY17 guidance is maintained (Please see detail